Morgan Stanley’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-102
| Closed | -$54 | – | 8391 |
|
|
2025
Q1 | $54 | Sell |
102
-3
| -3% | -$2 | ﹤0.01% | 7702 |
|
|
2024
Q4 | $549 | Buy |
105
+17
| +19% | +$89 | ﹤0.01% | 7335 |
|
|
2024
Q3 | $1.25K | Hold |
88
| – | – | ﹤0.01% | 7196 |
|
|
2024
Q2 | $1.42K | Sell |
88
-893
| -91% | -$14.4K | ﹤0.01% | 7114 |
|
|
2024
Q1 | $99.3K | Sell |
981
-795
| -45% | -$80.5K | ﹤0.01% | 5990 |
|
|
2023
Q4 | $41.9K | Buy |
1,776
+535
| +43% | +$12.6K | ﹤0.01% | 6437 |
|
|
2023
Q3 | $25.1K | Buy |
1,241
+34
| +3% | +$687 | ﹤0.01% | 6419 |
|
|
2023
Q2 | $31.4K | Hold |
1,207
| – | – | ﹤0.01% | 6391 |
|
|
2023
Q1 | $25.1K | Buy |
1,207
+72
| +6% | +$1.5K | ﹤0.01% | 6547 |
|
|
2022
Q4 | $23.2K | Sell |
1,135
-691
| -38% | -$14.1K | ﹤0.01% | 6626 |
|
|
2022
Q3 | $51K | Sell |
1,826
-737
| -29% | -$20.6K | ﹤0.01% | 6400 |
|
|
2022
Q2 | $69K | Buy |
2,563
+935
| +57% | +$25.2K | ﹤0.01% | 6461 |
|
|
2022
Q1 | $131K | Buy |
1,628
+86
| +6% | +$6.92K | ﹤0.01% | 6149 |
|
|
2021
Q4 | $314K | Sell |
1,542
-196
| -11% | -$39.9K | ﹤0.01% | 5816 |
|
|
2021
Q3 | $562K | Buy |
1,738
+122
| +8% | +$39.5K | ﹤0.01% | 5420 |
|
|
2021
Q2 | $419K | Buy |
1,616
+1,033
| +177% | +$268K | ﹤0.01% | 5634 |
|
|
2021
Q1 | $224K | Buy |
583
+477
| +450% | +$183K | ﹤0.01% | 5596 |
|
|
2020
Q4 | $44K | Buy |
+106
| New | +$44K | ﹤0.01% | 6198 |
|